Artivion | CRY - Debt


Artivion reported $317.78M in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 76.73M 521K Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 12.05B 19M Sep/2025
Edwards Lifesciences USD 700.3M 2.3M Sep/2025
Inogen USD 0 0 Jun/2022
Integra LifeSciences USD 2.01B 7.91M Sep/2025
J&J USD 45.8B 4.97B Sep/2025
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Orthofix International USD 137.23M 338K Sep/2024
Pfizer USD 60.85B 78M Sep/2025
ResMed USD 846.35M 178.06M Sep/2025
Stryker USD 14.86B 1.74B Dec/2025
Surmodics USD 29.55M 111K Sep/2024
Tandem Diabetes Care USD 449.28M 276K Sep/2025
Teleflex USD 2.77B 774M Sep/2025
Terumo JPY 159.87B 14.97B Sep/2025
Trinity Biotech USD 100.76M 7.05M Dec/2024